Vaccine independence requires a 21st-Century Connaught Labs, policy experts argue

Lindsay Borthwick
April 21, 2021

The federal and Ontario governments recently announced a $470-million investment to expand Sanofi Pasteur Limited’s vaccine manufacturing capability. But for Canada to be truly self-sufficient in vaccine development and production, critics say other models must be considered—including a 21st-century version of Connaught Labs. 

... Please become a Member or login to read the rest of this article ...


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.